gastric cancer
Conditions
Interventions
experimental group:Orally take Clostridium butyricum Capsule
Sponsors
The Second Affiliated Hospital of Nanchang University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Informed consent; 2. Gastric cancer was confirmed by clinical pathology; 3. The patient is generally in good condition, aged 18-70 years, without serious heart, lung, kidney, liver dysfunction and metabolic diseases; 4. No distant metastatic lesions were found; 5. The patient had no serious complications before the operation, and had not received radiotherapy or chemotherapy.
Exclusion criteria
Exclusion criteria: 1. Patients with severe heart, lung, kidney, liver dysfunction and metabolic diseases; 2. Distant metastasis was found; 3. Severe complications were found before surgery and received radiotherapy and chemotherapy; 4. Those who have immune diseases, cannot take orally or absorb digestive tract drugs or are allergic to probiotics; 5. Pregnant and lactating women; 6. Those with a history of allergies to test drugs or similar drugs, allergic physique, or current allergic diseases; 7. During the study period, it may be necessary to use drugs that are prohibited by the clinical trial protocol, such as antibiotics and other drugs that affect the intestinal flora; 8. Patients with autoimmune disease, immunodeficiency disease, or history of organ transplantation; 9. Participate in clinical trials of other antineoplastic drugs within 30 days before enrollment; 10. Patients with severe constipation after surgery; 11. Patients who were considered unsuitable for this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood routine;liver function;Kidney function;Electrolyte;Serum cytokines; | — |
Secondary
| Measure | Time frame |
|---|---|
| Fecal high-throughput sequencing;Fecal Metabolomics; | — |
Countries
China
Contacts
Public ContactDeng Xiaorong
The Second Affiliated Hospital of Nanchang University
Outcome results
None listed